Black Diamond doubles in value hours into Nasdaq debut, marking hot start to the 2020 IPO run
There are few allosteric therapies approved, but investors seem to like the idea — and the latest duo to pursue it.
Black Diamond Therapeutics, the young …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
